InvestorsHub Logo
Followers 21
Posts 2070
Boards Moderated 0
Alias Born 02/09/2006

Re: None

Wednesday, 09/02/2015 12:56:14 PM

Wednesday, September 02, 2015 12:56:14 PM

Post# of 1716
TrovaGene Looks To Revolutionize The Cancer Diagnostic Market

Nice little writeup by Jason Napodano.

http://seekingalpha.com/article/3482186-trovagene-looks-to-revolutionize-the-cancer-diagnostic-market?auth_param=ioo:1aue8md:b798fa08ff633878b4efbea5f0ad6abe&uprof=11

Summary

TrovaGene is pioneering a new field of cancer diagnostics by using a urine-based liquid biopsy platform.
The company has a number of CLIA available tests on the market and expects to spend the next few months collecting data and seeking reimbursement from payers.
So far the rollout looks to be going very well, but it is still early in the launch.
Nevertheless, despite being early I see significant potential for the company's platform I believe the shares are undervalued as of today.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News